Seladelpar Impurity 10

Seladelpar Impurity 10 is a designated process- or degradation-related impurity identified during the synthesis or stability testing of Seladelpar, a selective PPAR-δ agonist used for treating primary biliary cholangitis (PBC). Like other numbered impurities, it represents a structurally related compound that can arise from side reactions, incomplete conversion, oxidation, rearrangement, or degradation under stress conditions (such as heat, light, or moisture). It is monitored and controlled according to ICH impurity guidelines to ensure the drug substance and finished product meet regulatory standards for purity, safety, and quality.